The Clorox Company (CLX)
NYSE: CLX · Real-Time Price · USD
97.39
+1.41 (1.47%)
Jun 16, 2026, 11:09 AM EDT - Market open
The Clorox Company Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 1,187 | 167 | 202 | 367 | 183 | 319 |
Cash & Short-Term Investments | 1,187 | 167 | 202 | 367 | 183 | 319 |
Cash Growth | 425.22% | -17.33% | -44.96% | 100.55% | -42.63% | -63.38% |
Accounts Receivable | 671 | 821 | 695 | 688 | 681 | 604 |
Inventory | 588 | 523 | 637 | 696 | 755 | 752 |
Other Current Assets | 205 | 97 | 88 | 77 | 106 | 154 |
Total Current Assets | 2,651 | 1,608 | 1,622 | 1,828 | 1,725 | 1,829 |
Net Property, Plant & Equipment | 1,590 | 1,600 | 1,675 | 1,691 | 1,676 | 1,634 |
Other Intangible Assets | 551 | 566 | 681 | 712 | 884 | 918 |
Goodwill | 1,229 | 1,229 | 1,228 | 1,252 | 1,558 | 1,575 |
Other Long-Term Assets | 415 | 558 | 545 | 462 | 315 | 378 |
Total Assets | 6,436 | 5,561 | 5,751 | 5,945 | 6,158 | 6,334 |
Accounts Payable | 1,479 | 1,828 | 1,486 | 1,659 | 1,469 | 1,675 |
Short-Term Debt | 1,591 | 4 | 4 | 50 | 237 | - |
Current Portion of Long-Term Debt | - | - | - | - | - | 300 |
Current Portion of Leases | 85 | 87 | 84 | 87 | 78 | 81 |
Other Current Liabilities | - | - | - | 121 | - | - |
Total Current Liabilities | 3,155 | 1,919 | 1,574 | 1,917 | 1,784 | 2,056 |
Long-Term Debt | 2,487 | 2,484 | 2,481 | 2,477 | 2,474 | 2,484 |
Long-Term Leases | 323 | 305 | 334 | 310 | 314 | 301 |
Other Long-Term Liabilities | 379 | 371 | 870 | 853 | 857 | 901 |
Total Long-Term Liabilities | 3,189 | 3,160 | 3,685 | 3,640 | 3,645 | 3,686 |
Total Liabilities | 6,344 | 5,079 | 5,259 | 5,557 | 5,429 | 5,742 |
Common Stock | 131 | 131 | 131 | 131 | 131 | 131 |
Treasury Stock | -1,584 | -1,404 | -1,186 | -1,246 | -1,346 | -1,396 |
Additional Paid-in Capital | 1,315 | 1,319 | 1,288 | 1,245 | 1,202 | 1,186 |
Accumulated Other Comprehensive Income | -152 | -157 | -155 | -493 | -479 | -546 |
Retained Earnings | 223 | 432 | 250 | 583 | 1,048 | 1,036 |
Total Common Shareholders' Equity | -67 | 321 | 328 | 220 | 556 | 411 |
Minority Interest | 159 | 161 | 164 | 168 | 173 | 181 |
Shareholders' Equity | 92 | 482 | 492 | 388 | 729 | 592 |
Total Liabilities & Equity | 6,436 | 5,561 | 5,751 | 5,945 | 6,158 | 6,334 |
Total Debt | 4,486 | 2,880 | 2,903 | 2,924 | 3,103 | 3,166 |
Net Cash (Debt) | -3,299 | -2,713 | -2,701 | -2,557 | -2,920 | -2,847 |
Net Cash Per Share | -26.91 | -21.83 | -21.64 | -20.59 | -23.57 | -22.36 |
Book Value | -67 | 321 | 328 | 220 | 556 | 411 |
Book Value Per Share | -0.55 | 2.58 | 2.63 | 1.77 | 4.49 | 3.23 |
Tangible Book Value | -1,847 | -1,474 | -1,581 | -1,744 | -1,886 | -2,082 |
Tangible Book Value Per Share | -15.06 | -11.86 | -12.67 | -14.04 | -15.22 | -16.36 |